Here, we predicted the response of different NRP expression levels to immune checkpoint inhibitors in PAAD using the TIDE algorithm, a tool to evaluate the dysfunction of tumor-infiltrating cytotoxic T lymphocytes and the rejection of it by immunosuppressive factors based on gene expression [16]. The gene discussed is NRP1; the disease is neoplasm.